Literature DB >> 18026910

Boron distribution in the normal rat brain after intravenous injection of boronophenylalanine-fructose.

Yasushi Shibata1.   

Abstract

Boron neutron capture therapy (BNCT) is an experimental form of radiation therapy for malignant brain tumors and peripheral melanoma. The micro-distribution of the boron compound is critical to determine the radiation effects for both tumors and normal tissue. In the current dose calculation of BNCT, normal brain tissue is considered to have a homogeneous boron concentration. The purpose of this study was to examine the structure-specific boron concentration in normal rat neural tissue. At 10, 30 and 60 min after intravenous injection of 300 mg/kg boronophenylalanine-fructose to 10-week-old CD Fisher rats, neural tissue and blood were collected. Various neural structures were anatomically and histologically identified and specific boron concentrations were analyzed using high-resolution quantitative autoradiography. At 60 min after the injection, only the pituitary gland showed a higher boron concentration than that in blood, with the former being threefold higher. All other neural structures showed lower boron concentrations than that in blood. The present study thus demonstrated an extremely high boron concentration in the pituitary gland following intravenous injection of boronophenylalanine-fructose. In clinical trials of BNCT using an epithermal neutron beam, the radiation dose to the pituitary gland should be carefully evaluated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18026910     DOI: 10.1007/s11060-007-9494-0

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  50 in total

1.  A dose response analysis of injury to cranial nerves and/or nuclei following proton beam radiation therapy.

Authors:  M M Urie; B Fullerton; H Tatsuzaki; S Birnbaum; H D Suit; K Convery; S Skates; M Goitein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

2.  Monte Carlo treatment planning and high-resolution alpha-track autoradiography for neutron capture therapy.

Authors:  R G Zamenhof; S Clement; K Lin; C Lui; D Ziegelmiller; O K Harling
Journal:  Strahlenther Onkol       Date:  1989 Feb-Mar       Impact factor: 3.621

Review 3.  Boron neutron capture therapy of cancer: current status and future prospects.

Authors:  Rolf F Barth; Jeffrey A Coderre; M Graça H Vicente; Thomas E Blue
Journal:  Clin Cancer Res       Date:  2005-06-01       Impact factor: 12.531

4.  Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.

Authors:  J A Coderre; A D Chanana; D D Joel; E H Elowitz; P L Micca; M M Nawrocky; M Chadha; J O Gebbers; M Shady; N S Peress; D N Slatkin
Journal:  Radiat Res       Date:  1998-02       Impact factor: 2.841

5.  Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy.

Authors:  E H Elowitz; R M Bergland; J A Coderre; D D Joel; M Chadha; A D Chanana
Journal:  Neurosurgery       Date:  1998-03       Impact factor: 4.654

Review 6.  The radiation biology of boron neutron capture therapy.

Authors:  J A Coderre; G M Morris
Journal:  Radiat Res       Date:  1999-01       Impact factor: 2.841

7.  Radiation sensitivity of visual and oculomotor pathways.

Authors:  K A Leber; J Berglöff; G Langmann; M Mokry; O Schröttner; G Pendl
Journal:  Stereotact Funct Neurosurg       Date:  1995       Impact factor: 1.875

8.  Boron distribution analysis by alpha-autoradiography.

Authors:  M Abe; K Amano; K Kitamura; J Tateishi; H Hatanaka
Journal:  J Nucl Med       Date:  1986-05       Impact factor: 10.057

9.  A novel approach to the microdosimetry of neutron capture therapy. Part I. High-resolution quantitative autoradiography applied to microdosimetry in neutron capture therapy.

Authors:  G R Solares; R G Zamenhof
Journal:  Radiat Res       Date:  1995-10       Impact factor: 2.841

10.  Boron microlocalization in oral mucosal tissue: implications for boron neutron capture therapy.

Authors:  G M Morris; D R Smith; H Patel; S Chandra; G H Morrison; J W Hopewell; M Rezvani; P L Micca; J A Coderre
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.